bpc-157 synthetic pentadecapeptide derived from human gastric juice Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review BPC 157- Reaction / Application

Example: 80kg person = 200-320mcg per injection Injection location matters: Unlike systemic peptides, BPC-157 works best when injected near the injury site

Consider working with a registered dietitian for personalized nutrition guidance during weight loss

Professional-grade pharmaceutical formulation guarantees that preclinical research and clinical trials were done to prove the stability, safety, and efficiency of the therapy option

WADA 2026 Prohibited List Status (Section S0) BPC-157 is named explicitly on the World Anti-Doping Agency 2025 and 2026 Prohibited Lists under section S0 (Non-Approved Substances), prohibited at all times in and out of competition

The peptide repairs intestinal mucosal damage, restores tight junction integrity, normalizes gastric emptying, protects against NSAID-induced ulcers, and promotes healing of inflammatory lesions